SOCS5 has been recognized as a target of miR-301a, because miR-301a inhibited the SOCS5 expression, leading to induction of JAK/STAT3 signaling, and was linked to poor survival of pancreatic cancer patients.114. Here, SOCS5 is linked to pancreatic neoplasm.